Based on the results of multiple prospective randomized trials, the implantable cardioverter defibrillator (ICD) has become the dominant strategy for primary and secondary prevention of sudden cardiac death. When used in conjunction with cardiac resynchronization...
CITATION STYLE
Saba, S., & Mark Estes, N. A. (2017). Implantable and Wearable Defibrillator Therapy (pp. 131–142). https://doi.org/10.1007/978-3-319-58000-5_11
Mendeley helps you to discover research relevant for your work.